Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis

from Cancer via ola Kala on Inoreader http://ift.tt/2px5jIY
via IFTTT